Jodie Beauchamp

Recommended Articles

• Understanding Social Communication Disorder Could Benefit Autism Diagnosis

  The definition of autism is ever redefined. As doctors, researchers, and parents learn more and more about this neurodevelopmental disorder, it’s essential to reevaluate past knowledge and ideas. This is especially important with autism as it is not a simple on-off disease, but rather, encompasses...

• 10 Tips For Dealing With Fibro Fog

  Although the major symptoms of fibromyalgia are widespread pain and chronic fatigue, many individuals report a feeling of confusion and forgetfulness. This feeling is often referred to as the “fibro fog”. The cause of these cognitive difficulties is unknown, but may be attributable to the sleep...

• According To New Research The Juvenile Arthritis Diagnosis Is Improving

  Arthritis has been at the center of countless medical research in recent years, mainly due to the pain and limitations it places on its sufferers. Arthritis is also often thought to be a condition regulated to the elderly and older adults, but this is not always the case. Many children and young...

• Can Certain Lifestyle Choices Influence the Symptoms of Multiple Sclerosis?

  Multiple sclerosis (MS) is an illness that affects the body’s nervous system and whose cure has yet to be found. MS is characterized by varying signs and symptoms depending on which part of the nervous system is affected. The main and most common signs and symptoms observable in most patients...

• Penicillin and Other Drugs in the Same Class

  About PenicillinPenicillin is an antibiotic derived from the Penicillium notatum mold. In 1928, a Scottish bacteriologist named Alexander Fleming discovered penicillin. Since Fleming's discovery, several penicillins have been derived through modifying the mold's original structure to produce...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...